CDK9 was found to be highly expressed in invasive breast carcinoma (fold change = 1.725) in the TCGA dataset, and in invasive lobular breast carcinoma (fold change=1.778) in Turashvili’s dataset. This evidence concerns the gene CDK9 and invasive breast carcinoma.